Cargando…

Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109

Detalles Bibliográficos
Autores principales: Yu, Albert, Dai, Xiaoyong, Wang, Zixian, Chen, Huaqing, Guo, Bing, Huang, Laiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599890/
https://www.ncbi.nlm.nih.gov/pubmed/36291049
http://dx.doi.org/10.3390/bios12100794
_version_ 1784816704891650048
author Yu, Albert
Dai, Xiaoyong
Wang, Zixian
Chen, Huaqing
Guo, Bing
Huang, Laiqiang
author_facet Yu, Albert
Dai, Xiaoyong
Wang, Zixian
Chen, Huaqing
Guo, Bing
Huang, Laiqiang
author_sort Yu, Albert
collection PubMed
description
format Online
Article
Text
id pubmed-9599890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95998902022-10-27 Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109 Yu, Albert Dai, Xiaoyong Wang, Zixian Chen, Huaqing Guo, Bing Huang, Laiqiang Biosensors (Basel) Correction MDPI 2022-09-27 /pmc/articles/PMC9599890/ /pubmed/36291049 http://dx.doi.org/10.3390/bios12100794 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Yu, Albert
Dai, Xiaoyong
Wang, Zixian
Chen, Huaqing
Guo, Bing
Huang, Laiqiang
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title_full Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title_fullStr Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title_full_unstemmed Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title_short Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
title_sort correction: yu et al. recent advances of mesoporous silica as a platform for cancer immunotherapy. biosensors 2022, 12, 109
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599890/
https://www.ncbi.nlm.nih.gov/pubmed/36291049
http://dx.doi.org/10.3390/bios12100794
work_keys_str_mv AT yualbert correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109
AT daixiaoyong correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109
AT wangzixian correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109
AT chenhuaqing correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109
AT guobing correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109
AT huanglaiqiang correctionyuetalrecentadvancesofmesoporoussilicaasaplatformforcancerimmunotherapybiosensors202212109